Keywords: Molecular Imaging, probes and targets, hyperpolarization
Motivation: The emerging hyperpolarized MRI has been intrinsically limited for molecules with smaller molecular weights(M.W.~200) due to the limitation related to the long-standing bottleneck in their shorter lifetimes. Therefore, clinically promising peptide-based hyperpolarized probes with larger molecular weights have not been possible.
Goal(s): We demonstrate our rationally designed structural-framework enables us to directly observe in vivo metabolic activities of a tripeptide, glutathione(M.W.300~), which plays a central role in cellular metabolisms.
Approach: Designing hyperpolarized 13C-probes rationally and monitoring treatment responses on tumor xenografts were conducted.
Results: The novel hyperpolarized 13C-GSH can successfully detect site-specific enzymatic activities in vivo and monitor treatment responses on tumor xenografts.
Impact: This principal framework will pave the way for the future development of hyperpolarized probes, tumor characterizations, and advanced molecular imaging on clinically significant metabolic activities further, which can possibly lead to better prognostics, and earlier response monitoring in cancer treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords